# Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the <scp>CREDENCE</scp> trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mediators-between-canagliflozin-and-renoprotection-vary-depending-on-patient/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yohei Doi,Takayuki Hamano,Satoshi Yamaguchi,Yusuke Sakaguchi,Jun‐Ya Kaimori,Yoshitaka Isaka |
| Citations | 10 |
| DOI | 10.1111/dom.15191 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15191 |
| OpenAlex ID | https://openalex.org/W4382600092 |
| PMID | 37385955 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Yohei Doi](https://scholariq.org/researchers/yohei-doi-2/)
- [Yusuke Sakaguchi](https://scholariq.org/researchers/yusuke-sakaguchi/)
- [Satoshi Yamaguchi](https://scholariq.org/researchers/satoshi-yamaguchi/)
- [Takayuki Hamano](https://scholariq.org/researchers/takayuki-hamano/)
- [Yoshitaka Isaka](https://scholariq.org/researchers/yoshitaka-isaka-2/)

## Paper funders

- [Yale University](https://scholariq.org/funders/yale-university/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.